Physician

Syed Zulfiqar Ahmed, MD

According to 2025 Medicare claims, Syed Ahmed, MD (NPI: 1255314407) practices internal medicine in the Elizabethtown, KY market, with the plurality of this provider's patient population coming from Hardin, KY. This provider's primary affiliated billing organization is HEALTHWAY INTERNAL MEDICINE & PEDIATRICS PLLC (NPI: 1881974160; TIN: 45-3027478) and primary practice location at 42701-2521. Ahmed is affiliated with the PBACO Holding, LLC (ACO ID: A1001), participating under the MSSP model.

Ahmed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 204 traditional Medicare patients, billed 2,551 HCPCS/CPT codes, and received $108,575 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 5,584 prescription claims across 386 beneficiaries totaling $550,013 in drug costs, led by Jardiance (Empagliflozin). DME data shows 12 claims. Open Payments data shows 37 records totaling $625. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $155,776 to $108,575. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and declined steadily, from $24,397 to $2,008.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	432	3,318	$155,776
2016	389	4,338	$191,819
2017	402	5,793	$226,684
2018	370	3,679	$161,588
2019	321	2,482	$118,291
2020	278	2,479	$111,113
2021	262	2,379	$133,808
2022	227	1,966	$115,949
2023	207	1,748	$98,621
2024	204	2,551	$108,575

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	397	7,257	$377,756
2016	407	8,554	$470,526
2017	410	10,076	$603,574
2018	396	8,008	$525,572
2019	325	5,338	$428,334
2020	264	4,013	$480,025
2021	320	4,309	$425,825
2022	361	4,407	$448,345
2023	350	4,914	$591,435
2024	386	5,584	$550,013

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	68	334	$10,737
2016	72	284	$5,014
2017	62	305	$3,665
2018	60	252	$3,842
2019	20	86	$912
2020	14	63	$3,011
2021	N/R	95	$4,422
2022	N/R	37	$3,363
2023	11	21	$470
2024	N/R	12	$235

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	120	120	$124
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	159	449	$85
G0444	Annual depression screening, 5 to 15 minutes	120	120	$17
G0442	Annual alcohol misuse screening, 5 to 15 minutes	135	135	$17
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	173	532	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	80	4,457	$85,583
Eliquis	Apixaban	60	3,810	$61,442
Januvia	Sitagliptin Phosphate	42	2,880	$51,626
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	29	1,650	$34,577
Rybelsus	Semaglutide	19	990	$31,765

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	12	$235

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	37	$625	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Syed Zulfiqar Ahmed, MD?

Tedicare shows public-source Medicare data for Syed Zulfiqar Ahmed, MD (NPI 1255314407), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Syed Zulfiqar Ahmed, MD have ACO affiliation data?

Syed Zulfiqar Ahmed, MD is shown with ACO affiliation data for PBACO Holding, LLC (MSSP, ACO ID A1001).

What billing organization is linked to Syed Zulfiqar Ahmed, MD?

Syed Zulfiqar Ahmed, MD is linked to HEALTHWAY INTERNAL MEDICINE & PEDIATRICS PLLC (billing NPI 1881974160) in the available physician profile data.

Does Syed Zulfiqar Ahmed, MD have Open Payments data?

Syed Zulfiqar Ahmed, MD has 37 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.